Home › Funds › Vestal Point Capital, LP › COGT

Vestal Point Capital, LP position in COGT

COGENT BIOSCIENCES INC · Health Care

Vestal Point Capital, LP reported holding 475,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$15.2M, representing 0.39% of its reported portfolio and ranking #33 among its reported holdings. Vestal Point Capital, LP has disclosed COGT holdings in 4 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)475.00K sh
Reported value held$15.21M
Portfolio Weight0.39%
First reportedQ1 2025
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's COGT position evolved

Vestal Point Capital, LP first disclosed a stake in COGT in Q1 2025 at 3,000,000 shares (US$18.0M). The position peaked in Q1 2026 at 1,230,888 shares, worth US$47.4M. Across 4 filings, Vestal Point Capital, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 475,000 shares valued at US$15.2M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 3.00M $17.97M New
Q2 2025 3.08M $22.11M Add
Q1 2026 1.23M $47.38M New
Q3 2026 475.00K $15.21M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 51 other funds we track also report a position in COGT — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$190.7M), Fairmount Funds Management LLC (US$176.2M), Kynam Capital Management, LP (US$121.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has Vestal Point Capital, LP held COGT?

Vestal Point Capital, LP has disclosed COGT holdings in 4 of the last 7 reported quarters, going back to Q1 2025.

What is Vestal Point Capital, LP's current position in COGT?

As of Q3 2026, Vestal Point Capital, LP holds 475.00K shares of COGT (COGENT BIOSCIENCES INC), valued at $15.21M, representing 0.39% of its reported portfolio and ranking #33.

Has Vestal Point Capital, LP been buying or selling COGT?

In the latest 13F filing (Q3 2026), Vestal Point Capital, LP newly opened its position in COGT. The position peaked in Q1 2026 at 1.23M shares.

Which other funds hold COGT?

Other major institutional holders of COGT include DEERFIELD MANAGEMENT COMPANY, L.P., Fairmount Funds Management LLC, Kynam Capital Management, LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.